Sarcopenia and Cardiovascular Diseases

Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, a...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Circulation (New York, N.Y.) Ročník 147; číslo 20; s. 1534
Hlavní autori:	Damluji, Abdulla A, Alfaraidhy, Maha, AlHajri, Noora, Rohant, Namit N, Kumar, Manish, Al Malouf, Christina, Bahrainy, Samira, Ji Kwak, Min, Batchelor, Wayne B, Forman, Daniel E, Rich, Michael W, Kirkpatrick, James, Krishnaswami, Ashok, Alexander, Karen P, Gerstenblith, Gary, Cawthon, Peggy, deFilippi, Christopher R, Goyal, Parag
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 16.05.2023
Predmet:	Body Composition Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - therapy Humans Muscle Strength - physiology Muscle, Skeletal - metabolism Quality of Life Sarcopenia - diagnosis Sarcopenia - epidemiology Sarcopenia - therapy older adults cardiovascular diseases body mass index sarcopenia
ISSN:	1524-4539, 1524-4539
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic disease states. Early recognition of sarcopenia is important because it can provide an opportunity for interventions to reverse or delay the progression of muscle disorder, which may ultimately impact cardiovascular outcomes. Relying on body mass index is not useful for screening because many patients will have sarcopenic obesity, a particularly important phenotype among older cardiac patients. In this review, we aimed to: (1) provide a definition of sarcopenia within the context of muscle wasting disorders; (2) summarize the associations between sarcopenia and different cardiovascular diseases; (3) highlight an approach for a diagnostic evaluation; (4) discuss management strategies for sarcopenia; and (5) outline key gaps in knowledge with implications for the future of the field.
AbstractList	Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic disease states. Early recognition of sarcopenia is important because it can provide an opportunity for interventions to reverse or delay the progression of muscle disorder, which may ultimately impact cardiovascular outcomes. Relying on body mass index is not useful for screening because many patients will have sarcopenic obesity, a particularly important phenotype among older cardiac patients. In this review, we aimed to: (1) provide a definition of sarcopenia within the context of muscle wasting disorders; (2) summarize the associations between sarcopenia and different cardiovascular diseases; (3) highlight an approach for a diagnostic evaluation; (4) discuss management strategies for sarcopenia; and (5) outline key gaps in knowledge with implications for the future of the field.Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic disease states. Early recognition of sarcopenia is important because it can provide an opportunity for interventions to reverse or delay the progression of muscle disorder, which may ultimately impact cardiovascular outcomes. Relying on body mass index is not useful for screening because many patients will have sarcopenic obesity, a particularly important phenotype among older cardiac patients. In this review, we aimed to: (1) provide a definition of sarcopenia within the context of muscle wasting disorders; (2) summarize the associations between sarcopenia and different cardiovascular diseases; (3) highlight an approach for a diagnostic evaluation; (4) discuss management strategies for sarcopenia; and (5) outline key gaps in knowledge with implications for the future of the field. Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic disease states. Early recognition of sarcopenia is important because it can provide an opportunity for interventions to reverse or delay the progression of muscle disorder, which may ultimately impact cardiovascular outcomes. Relying on body mass index is not useful for screening because many patients will have sarcopenic obesity, a particularly important phenotype among older cardiac patients. In this review, we aimed to: (1) provide a definition of sarcopenia within the context of muscle wasting disorders; (2) summarize the associations between sarcopenia and different cardiovascular diseases; (3) highlight an approach for a diagnostic evaluation; (4) discuss management strategies for sarcopenia; and (5) outline key gaps in knowledge with implications for the future of the field.
Author	Batchelor, Wayne B Krishnaswami, Ashok Gerstenblith, Gary Goyal, Parag Forman, Daniel E Rich, Michael W Alfaraidhy, Maha Kumar, Manish Alexander, Karen P Cawthon, Peggy Damluji, Abdulla A Rohant, Namit N AlHajri, Noora deFilippi, Christopher R Bahrainy, Samira Al Malouf, Christina Ji Kwak, Min Kirkpatrick, James
Author_xml	– sequence: 1 givenname: Abdulla A orcidid: 0000-0002-8774-6416 surname: Damluji fullname: Damluji, Abdulla A organization: Johns Hopkins University School of Medicine, Baltimore, MD (A.A.D., M.A., G.G.) – sequence: 2 givenname: Maha orcidid: 0000-0003-3096-3222 surname: Alfaraidhy fullname: Alfaraidhy, Maha organization: Johns Hopkins University School of Medicine, Baltimore, MD (A.A.D., M.A., G.G.) – sequence: 3 givenname: Noora surname: AlHajri fullname: AlHajri, Noora organization: Cleveland Clinic, Abu Dhabi, United Arab Emirates (N.A.) – sequence: 4 givenname: Namit N surname: Rohant fullname: Rohant, Namit N organization: University of Arizona, Tucson (N.N.R., P.G.) – sequence: 5 givenname: Manish surname: Kumar fullname: Kumar, Manish organization: University of Connecticut, Hartford (M.K.) – sequence: 6 givenname: Christina surname: Al Malouf fullname: Al Malouf, Christina organization: Weill Cornell Medicine, New York, NY (C.A.M.) – sequence: 7 givenname: Samira orcidid: 0000-0003-2724-426X surname: Bahrainy fullname: Bahrainy, Samira organization: University of Washington, Seattle (S.B., J.K.) – sequence: 8 givenname: Min orcidid: 0000-0003-2778-3984 surname: Ji Kwak fullname: Ji Kwak, Min organization: University of Texas, Houston (M.J.K.) – sequence: 9 givenname: Wayne B orcidid: 0000-0002-3016-1150 surname: Batchelor fullname: Batchelor, Wayne B organization: Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, VA (A.A.D., W.B.B., C.R.D.) – sequence: 10 givenname: Daniel E orcidid: 0000-0002-5697-2189 surname: Forman fullname: Forman, Daniel E organization: University of Pittsburgh and the Pittsburgh Geriatric Research Education and Clinical Center, PA (D.E.F.) – sequence: 11 givenname: Michael W surname: Rich fullname: Rich, Michael W organization: Washington University, St Louis, MO (M.W.R.) – sequence: 12 givenname: James surname: Kirkpatrick fullname: Kirkpatrick, James organization: University of Washington, Seattle (S.B., J.K.) – sequence: 13 givenname: Ashok surname: Krishnaswami fullname: Krishnaswami, Ashok organization: Kaiser Permanente, San Jose, CA (A.K.) – sequence: 14 givenname: Karen P orcidid: 0000-0003-4418-1424 surname: Alexander fullname: Alexander, Karen P organization: Duke Clinical Research Institute, Duke University, Durham, NC (K.P.A.) – sequence: 15 givenname: Gary orcidid: 0000-0001-6046-6812 surname: Gerstenblith fullname: Gerstenblith, Gary organization: Johns Hopkins University School of Medicine, Baltimore, MD (A.A.D., M.A., G.G.) – sequence: 16 givenname: Peggy surname: Cawthon fullname: Cawthon, Peggy organization: University of California San Francisco (P.C.) – sequence: 17 givenname: Christopher R orcidid: 0000-0002-0660-4943 surname: deFilippi fullname: deFilippi, Christopher R organization: Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, VA (A.A.D., W.B.B., C.R.D.) – sequence: 18 givenname: Parag orcidid: 0000-0001-7474-3737 surname: Goyal fullname: Goyal, Parag organization: University of Arizona, Tucson (N.N.R., P.G.)
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/37186680$$D View this record in MEDLINE/PubMed
BookMark	eNpNj0tLw0AUhQep2If-BakbcZM4d5I7j2WIjxaKBW3X4WZyC5E0qRkj-O8tWEHO4juLjwNnKkZt17IQNyBjAA33-fI1366yzXL9ki2yGFQSS51KA2diAqjSKMXEjf71sZiG8C6l1InBCzFODFitrZyI2zfqfXfgtqY5tdU8p76quy8Kfmionz_UgSlwuBTnO2oCX504E9unx02-iFbr52WerSKPCeoIKNWlMhbQS-MsAJrSoAJpysQb9J4BgVMslaYdk6_IEZI1TiI7562aibvf3UPffQwcPot9HTw3DbXcDaFQFlJU7pijen1Sh3LPVXHo6z3138XfN_UDHwZTGA
CitedBy_id	crossref_primary_10_1007_s13679_024_00571_2 crossref_primary_10_1172_JCI185054 crossref_primary_10_1016_j_archger_2024_105728 crossref_primary_10_1161_HYPERTENSIONAHA_124_23011 crossref_primary_10_3389_fnut_2024_1378853 crossref_primary_10_14309_ajg_0000000000003544 crossref_primary_10_3389_fmed_2025_1500915 crossref_primary_10_3390_jcm13072078 crossref_primary_10_1007_s10068_025_01852_9 crossref_primary_10_3390_antiox13020224 crossref_primary_10_3390_molecules30092003 crossref_primary_10_1016_j_metabol_2024_155816 crossref_primary_10_1002_ptr_8420 crossref_primary_10_1161_JAHA_124_036941 crossref_primary_10_3390_healthcare13182309 crossref_primary_10_3390_biomedicines12092096 crossref_primary_10_3389_fcvm_2024_1410616 crossref_primary_10_3390_ijms26104673 crossref_primary_10_3390_ijms26146733 crossref_primary_10_1038_s41598_025_01133_9 crossref_primary_10_1111_ctr_70027 crossref_primary_10_3390_nu15133013 crossref_primary_10_4103_ETMJ_ETMJ_D_25_00003 crossref_primary_10_1016_j_bbrc_2024_150918 crossref_primary_10_1177_20552076241254904 crossref_primary_10_1016_j_rccl_2025_06_003 crossref_primary_10_1161_CIRCULATIONAHA_124_067676 crossref_primary_10_1186_s41043_025_00942_y crossref_primary_10_1016_j_clinsp_2025_100771 crossref_primary_10_1016_j_clgc_2025_102388 crossref_primary_10_1186_s40001_024_01873_w crossref_primary_10_3390_ph17121661 crossref_primary_10_1177_07334648241302457 crossref_primary_10_3389_fnut_2024_1445892 crossref_primary_10_3390_life14070832 crossref_primary_10_3389_fimmu_2024_1376544 crossref_primary_10_1186_s13089_023_00348_z crossref_primary_10_1002_ehf2_14984 crossref_primary_10_1016_j_jnha_2024_100316 crossref_primary_10_1161_JAHA_124_040099 crossref_primary_10_1186_s12877_024_05506_z crossref_primary_10_3390_ijms26083644 crossref_primary_10_3233_BMR_230423 crossref_primary_10_3389_fpsyg_2024_1387162 crossref_primary_10_3390_jcdd12050162 crossref_primary_10_1002_jcsm_13846 crossref_primary_10_3389_fpubh_2023_1296112 crossref_primary_10_1016_j_jacc_2025_08_012 crossref_primary_10_1093_eurjpc_zwaf432 crossref_primary_10_15656_kjgg_2025_26_2_66 crossref_primary_10_1016_j_archger_2025_105787 crossref_primary_10_1016_j_clnu_2025_03_001 crossref_primary_10_3390_jcm14082756 crossref_primary_10_3390_medicina60101648 crossref_primary_10_1016_j_metabol_2024_156130 crossref_primary_10_1111_joim_13808 crossref_primary_10_3390_jcm14113932 crossref_primary_10_3390_ijms25052715 crossref_primary_10_3389_fmed_2025_1549733 crossref_primary_10_3390_nu16070941 crossref_primary_10_3389_fnut_2024_1414103 crossref_primary_10_1016_j_puhe_2024_07_016 crossref_primary_10_1007_s11332_025_01405_x crossref_primary_10_1016_j_jchf_2024_08_018 crossref_primary_10_3390_ijms252212463 crossref_primary_10_1007_s41999_024_01039_1 crossref_primary_10_1016_j_mad_2024_111941 crossref_primary_10_1016_j_clnesp_2025_06_027 crossref_primary_10_3389_fgene_2024_1353908 crossref_primary_10_1519_JPT_0000000000000438 crossref_primary_10_1186_s12889_024_19473_y crossref_primary_10_3389_fendo_2025_1545706 crossref_primary_10_3389_fmolb_2025_1557218 crossref_primary_10_1016_j_jacadv_2023_100389 crossref_primary_10_4330_wjc_v17_i5_107320 crossref_primary_10_1016_j_numecd_2025_103971 crossref_primary_10_1186_s11556_025_00377_8 crossref_primary_10_3390_s24196423 crossref_primary_10_1016_j_bjae_2023_12_003 crossref_primary_10_3892_mmr_2024_13222 crossref_primary_10_1007_s41999_024_01042_6 crossref_primary_10_3389_fnut_2024_1503702 crossref_primary_10_1177_09287329241291323 crossref_primary_10_1007_s00592_025_02527_x crossref_primary_10_1007_s40520_025_03029_0 crossref_primary_10_1016_j_ebiom_2025_105580 crossref_primary_10_1016_j_exger_2025_112775 crossref_primary_10_1016_j_exger_2025_112778 crossref_primary_10_1097_MD_0000000000044312 crossref_primary_10_1007_s11357_025_01653_2 crossref_primary_10_3390_jcm14093182 crossref_primary_10_1007_s00223_025_01389_3 crossref_primary_10_1177_00315125251365292 crossref_primary_10_1016_j_jacadv_2025_101784 crossref_primary_10_1111_1756_185X_70340 crossref_primary_10_1016_j_freeradbiomed_2024_04_231 crossref_primary_10_1038_s41440_024_01898_y crossref_primary_10_1371_journal_pone_0315256 crossref_primary_10_4103_singaporemedj_SMJ_2024_233 crossref_primary_10_3390_jcm14124288 crossref_primary_10_1016_j_numecd_2025_104279 crossref_primary_10_3389_fmed_2025_1525205 crossref_primary_10_3390_medicina61071152 crossref_primary_10_1093_eurjcn_zvaf135 crossref_primary_10_1161_CIRCULATIONAHA_124_068203 crossref_primary_10_3390_biomedicines12071524 crossref_primary_10_3390_jcm12237483 crossref_primary_10_1161_CIRCRESAHA_125_325705 crossref_primary_10_2147_IJWH_S526607 crossref_primary_10_1016_j_maturitas_2025_108248 crossref_primary_10_1161_CIR_0000000000001289 crossref_primary_10_1016_j_numecd_2025_103864 crossref_primary_10_1007_s13105_025_01100_y crossref_primary_10_1097_MD_0000000000042700 crossref_primary_10_1007_s00330_024_10935_w crossref_primary_10_1007_s11332_025_01471_1 crossref_primary_10_3390_cells14141124 crossref_primary_10_3389_fcvm_2024_1377299 crossref_primary_10_3390_ijms242316951 crossref_primary_10_1093_eurjcn_zvae040 crossref_primary_10_3390_diagnostics14202259 crossref_primary_10_1080_15502783_2025_2564239 crossref_primary_10_1080_15502783_2025_2542368 crossref_primary_10_3389_fpubh_2025_1446862 crossref_primary_10_1016_j_asjsur_2024_09_102 crossref_primary_10_1186_s40001_023_01603_8 crossref_primary_10_1093_eurjpc_zwaf115 crossref_primary_10_3389_fnut_2024_1465486 crossref_primary_10_3389_fpubh_2023_1222636 crossref_primary_10_1097_CRD_0000000000000893 crossref_primary_10_1007_s40520_023_02671_w crossref_primary_10_3390_antiox13010113 crossref_primary_10_1002_ehf2_15047 crossref_primary_10_1016_j_clnesp_2025_03_169 crossref_primary_10_1016_j_ejim_2024_01_020 crossref_primary_10_1002_ehf2_15044 crossref_primary_10_3390_ijms26178527 crossref_primary_10_1016_j_metabol_2025_156359 crossref_primary_10_1016_j_clnu_2024_02_002 crossref_primary_10_1111_cns_14759 crossref_primary_10_1016_j_arth_2025_03_012 crossref_primary_10_1055_a_2577_2577 crossref_primary_10_17816_MSER658251 crossref_primary_10_1093_toxsci_kfaf077 crossref_primary_10_1097_MD_0000000000042494 crossref_primary_10_3892_ol_2025_15169 crossref_primary_10_1371_journal_pone_0322928 crossref_primary_10_3390_nu17020282 crossref_primary_10_1186_s40842_024_00179_4 crossref_primary_10_1111_ggi_15015 crossref_primary_10_1186_s13148_024_01727_6 crossref_primary_10_3390_jcm14124191 crossref_primary_10_1253_circrep_CR_25_0056 crossref_primary_10_1093_eurjcn_zvae017 crossref_primary_10_1007_s11897_024_00660_2 crossref_primary_10_1186_s12877_025_05723_0 crossref_primary_10_1038_s41598_025_87176_4 crossref_primary_10_1016_j_archger_2025_106023 crossref_primary_10_1016_j_nut_2025_112959 crossref_primary_10_1002_agm2_12328 crossref_primary_10_1016_j_maturitas_2025_108207 crossref_primary_10_1007_s11883_025_01329_4 crossref_primary_10_1186_s12933_025_02714_8 crossref_primary_10_1186_s12891_025_08775_w crossref_primary_10_3389_fnut_2024_1426855 crossref_primary_10_3390_nu17162703 crossref_primary_10_1186_s12889_025_23424_6 crossref_primary_10_1186_s12933_025_02681_0 crossref_primary_10_1186_s12889_023_17303_1 crossref_primary_10_1111_aor_14997 crossref_primary_10_1080_07853890_2024_2387302 crossref_primary_10_1007_s00586_024_08291_w crossref_primary_10_3389_fcvm_2025_1569681 crossref_primary_10_3390_jpm15030083 crossref_primary_10_1016_j_bpa_2025_08_008 crossref_primary_10_1016_j_bpa_2025_08_009 crossref_primary_10_1016_j_joca_2025_05_003 crossref_primary_10_3389_fmed_2024_1378846 crossref_primary_10_1210_clinem_dgad605 crossref_primary_10_1016_j_tcm_2025_01_004 crossref_primary_10_1097_HCR_0000000000000930 crossref_primary_10_5090_jcs_24_086 crossref_primary_10_1016_j_archger_2023_105160 crossref_primary_10_1016_j_jacadv_2024_100949 crossref_primary_10_15212_bioi_2023_0020 crossref_primary_10_1016_j_ejrad_2025_112212 crossref_primary_10_15829_1728_8800_2025_4230 crossref_primary_10_1186_s12916_024_03841_x crossref_primary_10_3389_fmed_2025_1589583 crossref_primary_10_1007_s12603_023_2023_9 crossref_primary_10_1111_acel_14198 crossref_primary_10_1016_j_maturitas_2025_108233 crossref_primary_10_1186_s43162_024_00388_4 crossref_primary_10_3389_fpubh_2025_1556033 crossref_primary_10_1007_s11934_025_01278_0 crossref_primary_10_1016_j_jchf_2025_01_016 crossref_primary_10_3389_fendo_2024_1452664 crossref_primary_10_3389_fpubh_2025_1614374 crossref_primary_10_1186_s12933_023_02109_7 crossref_primary_10_3389_fendo_2024_1387374 crossref_primary_10_3390_jcm12165233 crossref_primary_10_1080_07853890_2025_2534085 crossref_primary_10_1002_jcsm_70002 crossref_primary_10_1186_s12889_025_21933_y crossref_primary_10_1016_j_jhazmat_2025_138929 crossref_primary_10_56294_cid2025145 crossref_primary_10_1186_s12885_025_13772_2 crossref_primary_10_1016_j_jacc_2024_04_004 crossref_primary_10_1097_JCMA_0000000000001027 crossref_primary_10_1016_j_diabet_2025_101681 crossref_primary_10_1161_CIRCHEARTFAILURE_125_012805 crossref_primary_10_1002_ccd_70043 crossref_primary_10_3389_fphar_2023_1282357 crossref_primary_10_30579_mbse_2025_8_2_72 crossref_primary_10_1007_s00380_024_02379_5 crossref_primary_10_1038_s41598_025_90131_y crossref_primary_10_3390_healthcare13070776 crossref_primary_10_1210_clinem_dgaf002 crossref_primary_10_1016_j_exger_2024_112447 crossref_primary_10_3389_fendo_2025_1531394 crossref_primary_10_1002_ptr_8478 crossref_primary_10_1016_j_jacl_2025_06_005 crossref_primary_10_1016_j_lanepe_2025_101372 crossref_primary_10_3390_bios14120622 crossref_primary_10_1093_ajh_hpaf106 crossref_primary_10_1016_j_jacadv_2023_100421 crossref_primary_10_3389_fpubh_2024_1368933 crossref_primary_10_1007_s13273_025_00557_8 crossref_primary_10_1371_journal_pone_0303148 crossref_primary_10_1186_s12872_025_04673_0 crossref_primary_10_3389_fpubh_2025_1636857 crossref_primary_10_1265_ehpm_24_00351 crossref_primary_10_1016_j_diabres_2025_112209 crossref_primary_10_1002_mco2_70252 crossref_primary_10_1016_j_pnpbp_2025_111327 crossref_primary_10_1093_aje_kwae479 crossref_primary_10_1016_j_archger_2024_105520 crossref_primary_10_1111_dom_15728 crossref_primary_10_1159_000538980 crossref_primary_10_1007_s40266_024_01165_2 crossref_primary_10_3389_fcell_2024_1433857 crossref_primary_10_1016_j_jjcc_2025_04_016 crossref_primary_10_1016_j_exger_2025_112811 crossref_primary_10_1186_s12888_024_05885_y crossref_primary_10_1016_j_smhs_2025_03_004 crossref_primary_10_1007_s00261_023_04161_z crossref_primary_10_2214_AJR_25_32781 crossref_primary_10_1016_j_pdpdt_2025_104549 crossref_primary_10_1093_eurjpc_zwaf282 crossref_primary_10_1161_JAHA_124_040050 crossref_primary_10_1016_j_ajpc_2025_101060 crossref_primary_10_1093_eurheartj_ehaf131 crossref_primary_10_3390_nu16050654 crossref_primary_10_1016_j_bbrc_2024_150606 crossref_primary_10_4327_jsnfs_78_139 crossref_primary_10_1016_j_snb_2025_138126 crossref_primary_10_1002_jcsm_13650 crossref_primary_10_3389_fnut_2024_1395170 crossref_primary_10_5306_wjco_v16_i4_100309 crossref_primary_10_3390_jcm13051515 crossref_primary_10_1038_s41598_025_13371_y crossref_primary_10_1016_j_clnu_2025_06_007 crossref_primary_10_2196_69860 crossref_primary_10_1016_j_gerinurse_2025_103582 crossref_primary_10_3389_fcell_2024_1506450 crossref_primary_10_1016_j_gerinurse_2024_04_013 crossref_primary_10_3390_medicina61020247 crossref_primary_10_1002_jcsm_13521 crossref_primary_10_3389_fnut_2025_1529140 crossref_primary_10_1016_j_jacadv_2024_100877 crossref_primary_10_1016_j_clnu_2025_07_028 crossref_primary_10_1080_14740338_2024_2412234 crossref_primary_10_1016_j_clnu_2025_02_020 crossref_primary_10_1002_jcsm_13757 crossref_primary_10_1016_j_archger_2024_105438 crossref_primary_10_3390_molecules30071437 crossref_primary_10_3390_ijms26136525 crossref_primary_10_3390_antiox14060647 crossref_primary_10_2147_CIA_S517833 crossref_primary_10_1016_j_archger_2025_106027 crossref_primary_10_1161_JAHA_123_033571 crossref_primary_10_1161_CIRCRESAHA_125_325526 crossref_primary_10_1016_j_jnha_2025_100670 crossref_primary_10_1002_biof_2054 crossref_primary_10_1016_j_arr_2023_102043 crossref_primary_10_4274_tod_galenos_2025_26122 crossref_primary_10_1016_j_clnu_2024_09_003 crossref_primary_10_1186_s13690_025_01501_x crossref_primary_10_1080_02701367_2024_2409932 crossref_primary_10_1016_j_afos_2025_06_003 crossref_primary_10_1139_cjpp_2024_0201
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1161/CIRCULATIONAHA.123.064071
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology
EISSN	1524-4539
ExternalDocumentID	37186680
Genre	Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NIA NIH HHS grantid: P30 AG024827 – fundername: NIA NIH HHS grantid: R01 AG078153 – fundername: NIA NIH HHS grantid: U19 AG065188 – fundername: NIA NIH HHS grantid: R01 AG077179 – fundername: NIA NIH HHS grantid: R01 AG060499 – fundername: NIA NIH HHS grantid: R21 AG070804 – fundername: NIA NIH HHS grantid: P30 AG021334 – fundername: NCI NIH HHS grantid: R01 CA246695 – fundername: RRD VA grantid: I21 RX004409 – fundername: NIA NIH HHS grantid: R01 AG058883
GroupedDBID	--- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABQRW ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ADBBV ADCYY ADGGA ADHPY AE6 AEBDS AENEX AFCHL AFDTB AFEXH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW ASPBG AVWKF AWKKM AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODA ODMTH OGEVE OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RHF RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 AAFWJ ABPXF ABXYN ABZZY ACDOF ACZKN ADKSD ADSXY AE3 AFBFQ AFMBP AFNMH AHQVU AOQMC
ID	FETCH-LOGICAL-c5356-1a46b27815c07981157b752107b3c75cce151e45b26afeacda9a5a87905e99c82
IEDL.DBID	7X8
ISICitedReferencesCount	359
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00003017-202305160-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1524-4539
IngestDate	Wed Oct 01 13:49:10 EDT 2025 Wed Feb 19 02:02:34 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	20
Keywords	older adults cardiovascular diseases body mass index sarcopenia
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5356-1a46b27815c07981157b752107b3c75cce151e45b26afeacda9a5a87905e99c82
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23
ORCID	0000-0003-2724-426X 0000-0001-7474-3737 0000-0002-3016-1150 0000-0002-8774-6416 0000-0003-4418-1424 0000-0003-3096-3222 0000-0003-2778-3984 0000-0002-5697-2189 0000-0001-6046-6812 0000-0002-0660-4943
OpenAccessLink	https://pubmed.ncbi.nlm.nih.gov/PMC10180053
PMID	37186680
PQID	2814529292
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2814529292 pubmed_primary_37186680
PublicationCentury	2000
PublicationDate	2023-05-16 20230516
PublicationDateYYYYMMDD	2023-05-16
PublicationDate_xml	– month: 05 year: 2023 text: 2023-05-16 day: 16
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Circulation (New York, N.Y.)
PublicationTitleAlternate	Circulation
PublicationYear	2023
SSID	ssj0006375
Score	2.7374372
SecondaryResourceType	review_article
Snippet	Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1534
SubjectTerms	Body Composition Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - therapy Humans Muscle Strength - physiology Muscle, Skeletal - metabolism Quality of Life Sarcopenia - diagnosis Sarcopenia - epidemiology Sarcopenia - therapy
Title	Sarcopenia and Cardiovascular Diseases
URI	https://www.ncbi.nlm.nih.gov/pubmed/37186680 https://www.proquest.com/docview/2814529292
Volume	147
WOSCitedRecordID	wos00003017-202305160-00006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEB7USvHio_VRX2xBelvbJLtJ9iRltVRoS1ELvS1JNoUeuq2uCv57k-yW4kEQZCG3hTBM5puZb_gG4EYqiZBCqS-EtN0qrnyBqPCJYFQRqXSQOsn8ARuN-HQajcuGW16OVa5jogvU6VLZHnkbc2Q5QvPdrV59uzXKsqvlCo1tqBCTylivZtONWjglTmjXQFTgByGJqtB0QYKidvz4FE8GheBs33YEya3jtNDvmaZDnN7Bf-96CPtlrul1C-c4gi2d1aDezUydvfjyWp6b_nRt9RpUhyXJXofWs3F-u1VrLjyRpV78Y2TVuy8onfwYJr2Hl7jvl-sUfBUSqzYoAiox4yhUHRZxq7IjmUHvDpNEsVApbdBfB6HEVMxMPE5FJELBrYKXjiLF8QnsZMtMn4HHdBAxjKWpZ8KACWyKEqIxV0wY_Cd01oDm2jCJcVfLQYhMLz_yZGOaBpwW1k1Wha5GQphV3-Od8z_8fQF7dvG75fERvYTKzDxWfQW76vN9nr9dOz8w52g8_AZFCbnO
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sarcopenia+and+Cardiovascular+Diseases&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Damluji%2C+Abdulla+A&rft.au=Alfaraidhy%2C+Maha&rft.au=AlHajri%2C+Noora&rft.au=Rohant%2C+Namit+N&rft.date=2023-05-16&rft.eissn=1524-4539&rft.volume=147&rft.issue=20&rft.spage=1534&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.123.064071&rft_id=info%3Apmid%2F37186680&rft_id=info%3Apmid%2F37186680&rft.externalDocID=37186680
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon